Last reviewed · How we verify

NCT06229561

Soft Tissue Graft Versus Acellular Dermal Matrix in Preservation of Buccal Plate of Bone

Completed Phase 1, PHASE2 Last updated 29 January 2024
What this trial tests

Phase 1, PHASE2 trial testing Acellular Dermal Matrix in Comparative Study in 12 participants. Completed in 20 May 2023.

Timeline
18 January 2020
Primary endpoint
20 November 2022
20 May 2023

Quick facts

Lead sponsorFaculty of Dental Medicine for Girls
PhasePhase 1, PHASE2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment12
Start date18 January 2020
Primary completion20 November 2022
Estimated completion20 May 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Faculty of Dental Medicine for Girls — full company profile →

Who can join

Adults 20 to 50, any sex, with Comparative Study. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparative study between 2 groups to assess the feasibility of using Acellular dermal matrix vs Soft tissue Graft after immediate implant placement

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Acellular Dermal Matrix

Trials testing the same drug.

Other Faculty of Dental Medicine for Girls trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06229561.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing